Market Cap
$18.76B$765.41M+4.25%
Summary
- Current Value
- As of today, MRNA market cap is $19B, up +4.25% in the most recent trading session on
- Category
- Based on its current market cap, MRNA falls into the Large Cap category
- Historical Performance
- MRNA market cap is up +61.45% year-to-date, up +75.68% over the past 365 days
- All-Time High Comparison
- MRNA market cap is currently -90.41% below its historical high of $196B set on
- 3-Year Low Comparison
- MRNA market cap is +114.71% above its 3-year low of $9B reached on
- Sector Comparison
- MRNA market cap is higher than 94.19% of companies in Healthcare sector
Market Cap Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $19B | +4.3% | -2.4% | +12.3% | +61.5% | +75.7% | -63.4% | -73.1% | |
| Price | $47.30 | +4.3% | -3.9% | +10.6% | +60.4% | +71.3% | -64.8% | -72.8% | |
| Shares Outstanding | 396.59M | +1.5% | – | – | – | +2.5% | +4.0% | -1.2% | |
| PE Ratio | - | – | – | – | – | – | – | – | |
| TTM Revenue | $2.23B | +14.4% | – | +14.4% | – | -30.0% | -85.1% | -18.6% | |
| TTM EPS | -$4.75 | +34.6% | – | +34.6% | – | +45.6% | -141.0% | -478.5% | |
| $14.85B | +5.4% | -3.0% | +21.6% | +108.5% | +172.7% | -65.8% | -76.1% | ||
| TTM Dividend | - | – | – | – | – | – | – | – | |
| TTM Net Income | -$3.19B | -13.2% | – | -13.2% | – | +4.9% | -166.8% | -634.0% |
Market Cap Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | $22B | -14.9% | |
| 3M | $23B | -16.9% | |
| 6M | $23B | -16.9% | |
| 1Y | $23B | -16.9% | |
| 3Y | $64B | -70.6% | |
| 5Y | $196B | -90.4% | |
| All | $196B | -90.4% |
Market Cap Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | $18B | +4.3% | |
| 3M | $16B | +19.7% | |
| 6M | $9B | +114.7% | |
| 1Y | $9B | +114.7% | |
| 3Y | $9B | +114.7% | |
| 5Y | $9B | +114.7% | |
| All | $4B | +363.4% |
Market Cap History
| Date | Value | Change |
|---|---|---|
| $19B | +61.4% | |
| $12B | -27.6% | |
| $16B | -57.8% | |
| $38B | -45.1% | |
| $69B | -32.4% |
| Date | Value | Change |
|---|---|---|
| $102B | +145.7% | |
| $42B | +532.9% | |
| $7B | +31.1% | |
| $5B | - |
FAQ
What is the current market cap of MRNA?
As of today, MRNA market cap is $19B
What market cap category does MRNA fall into?
Based on its current market cap, MRNA falls into the Large Cap category
What is MRNA market cap today change?
MRNA market cap is up +4.25% today
What is 1-year change in MRNA market cap?
MRNA market cap is up +75.68% year-over-year
How far is MRNA market cap from its all-time high?
MRNA market cap is currently -90.41% below its historical high of $196B set on August 9, 2021
How does MRNA market cap rank versus sector peers?
MRNA market cap is higher than 94.19% of companies in Healthcare sector
Market Cap Formula
Market Cap = Price × Shares Outstanding
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000162828025053816/0001628280-25-053816-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna